Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
INR 56.0
(-0.37%)
INR 56.0
(-0.37%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 672.8 Million | 653.49 Million | 655 Million | 587.44 Million | 483.67 Million | 494.24 Million |
| Cost of Revenue | 325.7 Million | 322.57 Million | 357.42 Million | 356.57 Million | 259.8 Million | 260.33 Million |
| Gross Profit | 347.1 Million | 330.92 Million | 297.57 Million | 230.86 Million | 223.86 Million | 233.9 Million |
| Operating Expenses | 212.9 Million | 311.22 Million | 274.13 Million | 214.84 Million | 214.05 Million | 218.17 Million |
| Selling, General and Administrative Expenses | 223.41 Million | 106.2 Million | 95.12 Million | 76.5 Million | 79.82 Million | 91.09 Million |
| Research and Development Expenses | - | 1.24 Million | 1.61 Million | 1.41 Million | 1.25 Million | 339.82 Thousand |
| Other Expenses | 4.23 Million | 3.27 Million | 828 Thousand | 100.00 | 4.52 Million | -586.52 Thousand |
| Cost and Expenses | 655.68 Million | 633.79 Million | 631.56 Million | 571.42 Million | 473.86 Million | 478.51 Million |
| Operating Income | 17.12 Million | 19.69 Million | 23.45 Million | 15.91 Million | 9.05 Million | 14.93 Million |
| Interest Expense | 631 Thousand | 721 Thousand | 1.1 Million | 647 Thousand | 4.04 Million | 9.35 Million |
| Income Tax Expense | 6.11 Million | 6.96 Million | 7.27 Million | 5.88 Million | 1.98 Million | 3.48 Million |
| Earnings before Tax | 20.72 Million | 22.16 Million | 23.16 Million | 16.8 Million | 9.19 Million | 10.17 Million |
| Net Income | 14.61 Million | 15.2 Million | 15.89 Million | 10.92 Million | 7.2 Million | 6.69 Million |
| Earnings Per Share Basic | 1.51 | 1.61 | 1.99 | 1.54 | 1.02 | 0.94 |
| Earnings Per Share Diluted | 1.51 | 1.61 | 1.87 | 1.54 | 1.02 | 0.94 |
| Weighted Average Shares Outstanding | 9.67 Million | 9.43 Million | 7.99 Million | 7.08 Million | 7.08 Million | 7.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.67 Million | 9.43 Million | 8.5 Million | 7.08 Million | 7.08 Million | 7.08 Million |
| Gross Margin | 0.52 | 0.51 | 0.45 | 0.39 | 0.46 | 0.47 |
| EBIT Margin | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| EBITDA | 27.19 Million | 28.13 Million | 29.16 Million | 23.17 Million | 19.06 Million | 26.65 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 170.45 Million | 155.97 Million | 672.8 Million | 174.28 Million | 166.07 Million | 176.57 Million |
| Cost of Revenue | 117.87 Million | 88.56 Million | 432.26 Million | 113.02 Million | 82.98 Million | 94.45 Million |
| Gross Profit | 52.58 Million | 67.41 Million | 240.54 Million | 61.26 Million | 83.08 Million | 82.11 Million |
| Operating Expenses | 50.11 Million | 63.24 Million | 223.41 Million | 57.57 Million | 76.16 Million | 79.78 Million |
| Selling, General and Administrative Expenses | 50.11 Million | 63.24 Million | - | 57.57 Million | 49.36 Million | 53.34 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 449 Thousand | 3.08 Million | 4.23 Million | 267 Thousand | 870 Thousand | 10 Thousand |
| Cost and Expenses | 167.98 Million | 151.8 Million | 655.68 Million | 170.6 Million | 159.14 Million | 174.24 Million |
| Operating Income | 2.47 Million | 4.17 Million | 17.12 Million | 3.68 Million | 6.92 Million | 2.33 Million |
| Interest Expense | 212 Thousand | 73 Thousand | 631 Thousand | 176 Thousand | 148 Thousand | 234 Thousand |
| Income Tax Expense | 1.04 Million | 1.24 Million | 6.11 Million | 1.71 Million | 2.13 Million | 1.01 Million |
| Earnings before Tax | 2.71 Million | 7.19 Million | 20.72 Million | 3.77 Million | 7.64 Million | 2.1 Million |
| Net Income | 1.66 Million | 5.94 Million | 14.61 Million | 2.06 Million | 5.5 Million | 1.09 Million |
| Earnings Per Share Basic | 0.17 | 0.62 | - | 0.21 | 0.57 | 0.11 |
| Earnings Per Share Diluted | 0.17 | 0.62 | - | 0.21 | 0.57 | 0.11 |
| Weighted Average Shares Outstanding | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million | 9.66 Million |
| Gross Margin | 0.31 | 0.43 | 0.36 | 0.35 | 0.50 | 0.47 |
| EBIT Margin | 0.02 | 0.04 | - | 0.03 | 0.05 | 0.02 |
| Profit Margin | 0.01 | 0.04 | 0.02 | 0.01 | 0.03 | 0.01 |
| EBITDA | 4.06 Million | 6.04 Million | - | 5.1 Million | 9.12 Million | 3.56 Million |
| Earnings Before Tax Margin | 0.01 | 0.03 | 0.03 | 0.02 | 0.04 | 0.01 |
PEBB
4921
3591
ARZTY
AHLEAST
601069